FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
For FDA Voices older than 2023, please view the archived page.
Sub-Topic Paragraphs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA Weighs in on the Development and Use of Digitally Derived Measures for Clinical Investigations
Unlocking the Full Potential of Digital Health Technologies to Support Medical Product Development and Innovation
America Must Address Early Clinical Development
FDA is reimagining the IND Process Through Clarifying Requirements and Launching the Expedited IND Pilot.
Some table information
| Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
|---|